AbbVie Financial Ratios
NYSE: ABBVHealth CareBiotechnology: Pharmaceutical PreparationsUSD
276.47+4.05 (+1.49%)
At close: Oct 9, 4:01 PM ET · Delayed 15 min
AbbVie ratio analysis
AbbVie earned a net margin of 6.9% in FY 2025, down from 7.6% a year earlier. Gross margin was 70.2% compared with a median of 70.0% over the prior 9 years. At the end of FY 2025, ABBV traded at 97.2 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 16.8 to 97.2, with a median of 26.8.
Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
AbbVie financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 97.17 | 75.82 | 56.97 | 24.38 | 20.99 | 39.39 | 16.80 | 24.34 | 29.31 | 17.25 |
| Price / sales | 6.63 | 5.69 | 5.04 | 4.93 | 4.26 | 3.90 | 3.95 | 4.19 | 5.47 | 3.96 |
| Price / book | — | 96.41 | 26.45 | 16.59 | 15.55 | 13.66 | — | — | 30.28 | 21.91 |
| Gross margin | 70.2% | 70.0% | 62.4% | 70.0% | 69.0% | 66.4% | 77.6% | 76.4% | 75.0% | 77.3% |
| Operating margin | 24.6% | 16.2% | 23.5% | 31.2% | 31.9% | 24.8% | 39.0% | 19.5% | 33.8% | 36.4% |
| Net margin | 6.9% | 7.6% | 9.0% | 20.4% | 20.5% | 10.1% | 23.7% | 17.4% | 18.8% | 23.2% |
| Free cash flow margin | 29.1% | 31.7% | 40.6% | 41.8% | 39.1% | 36.7% | 38.4% | 39.0% | 33.4% | 25.6% |
| Return on equity (ROE) | — | 128.7% | 46.9% | 68.6% | 74.9% | 35.3% | — | — | 104.2% | 128.4% |
| Return on assets (ROA) | 3.2% | 3.2% | 3.6% | 8.5% | 7.9% | 3.1% | 8.8% | 9.6% | 7.5% | 9.0% |
| Debt / equity | — | 20.19 | 5.73 | 3.67 | 4.98 | 6.58 | — | — | 7.33 | 7.95 |
| Current ratio | 0.67 | 0.66 | 0.87 | 0.96 | 0.79 | 0.84 | 3.18 | 0.98 | 1.28 | 1.65 |
| Revenue growth | 8.6% | 3.7% | -6.4% | 3.3% | 22.7% | 37.7% | 1.6% | 16.1% | 10.1% | 12.2% |
| EPS growth | -1.3% | -12.1% | -59.0% | 2.8% | 137.1% | -48.5% | 44.3% | 10.9% | -9.1% | 16.0% |